Background and purpose: Endothelial dysfunction may play a role in the pathogenesis of the slow coronary flow (SCF) phenomenon. A detailed examination of blood cellular components has not been performed for this condition. We investigated the relationship between SCF and whole blood cell counts. Method: Records of 17,315 patients who underwent coronary angiography between January 2006 and December 2012 were evaluated retrospectively. A total of 146 patients with SCF were compared with 148 patients with normal coronary arteries according to demographic data, complete blood count, and biochemical parameters. Results: The following parameters were significantly higher in SCF patients than in patients with normal coronary arteries: percentage o...
Background: In some patients with chest pain, selective coronary angiography reveals slow contrast a...
OBJECTIVE: The pathophysiology of coronary slow flow has not been clearly defined, although multiple...
Objective: Coronary Artery Disease (CAD) is the leading cause of morbidity and mortality all around ...
WOS: 000331424100021PubMed: 24012331Background and purpose: Endothelial dysfunction may play a role ...
AbstractBackground and purposeEndothelial dysfunction may play a role in the pathogenesis of the slo...
AbstractBackground and purposeEndothelial dysfunction may play a role in the pathogenesis of the slo...
OBJECTIVE: An elevated red cell distribution width has been recognized as a predictor of variou...
Objective: The coronary slow flow phenomenon (CSFP), which is characterized by delayed distal vessel...
OBJECTIVE: At present, the precise pathophysiology of the slow coronary flow phenomenon (SCFP) is st...
Background: Slow coronary flow (SCF) is characterized by delayed opacification of epicardial coronar...
Background: Slow coronary flow (SCF) is characterized by delayed opacification of epicardial coronar...
Objective At present, the precise pathophysiology of the slow coronary flow phenomenon (SCFP) is sti...
Objectives: The coronary slow-flow (CSF) phenomenon is a unique clinical angiographic entity defined...
Objectives: The coronary slow-flow (CSF) phenomenon is a unique clinical angiographic entity defined...
OBJECTIVE: The pathophysiology of coronary slow flow has not been clearly defined, although multiple...
Background: In some patients with chest pain, selective coronary angiography reveals slow contrast a...
OBJECTIVE: The pathophysiology of coronary slow flow has not been clearly defined, although multiple...
Objective: Coronary Artery Disease (CAD) is the leading cause of morbidity and mortality all around ...
WOS: 000331424100021PubMed: 24012331Background and purpose: Endothelial dysfunction may play a role ...
AbstractBackground and purposeEndothelial dysfunction may play a role in the pathogenesis of the slo...
AbstractBackground and purposeEndothelial dysfunction may play a role in the pathogenesis of the slo...
OBJECTIVE: An elevated red cell distribution width has been recognized as a predictor of variou...
Objective: The coronary slow flow phenomenon (CSFP), which is characterized by delayed distal vessel...
OBJECTIVE: At present, the precise pathophysiology of the slow coronary flow phenomenon (SCFP) is st...
Background: Slow coronary flow (SCF) is characterized by delayed opacification of epicardial coronar...
Background: Slow coronary flow (SCF) is characterized by delayed opacification of epicardial coronar...
Objective At present, the precise pathophysiology of the slow coronary flow phenomenon (SCFP) is sti...
Objectives: The coronary slow-flow (CSF) phenomenon is a unique clinical angiographic entity defined...
Objectives: The coronary slow-flow (CSF) phenomenon is a unique clinical angiographic entity defined...
OBJECTIVE: The pathophysiology of coronary slow flow has not been clearly defined, although multiple...
Background: In some patients with chest pain, selective coronary angiography reveals slow contrast a...
OBJECTIVE: The pathophysiology of coronary slow flow has not been clearly defined, although multiple...
Objective: Coronary Artery Disease (CAD) is the leading cause of morbidity and mortality all around ...